Sign inJoin waitlistJoin the waitlist

Elizabeth M. Gaughan

Hematology & Oncology · University of Virginia Physicians Group

Credentials: · · ·

History

Research

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma
Clinical Cancer Research · 2018 · 134 citations
Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature
Journal for ImmunoTherapy of Cancer · 2016 · Last of 6 authors · Corresponding · 86 citations
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients
Journal for ImmunoTherapy of Cancer · 2019 · 83 citations

Craig Slingluff
12 papers
Kathleen Haden
6 papers
Douglas Johnson
4 papers
James Isaacs
4 papers
Patrick Dillon
4 papers
Ryan Gentzler
4 papers
Varinder Kaur
4 papers
WG
William Grosh
4 papers
Aarti Asnani
3 papers
Alejandro Gru
3 papers
Anna Narezkina
3 papers
Danette Flint
3 papers

Clinical trials

A Clinical Trial to Evaluate a Melanoma Helper Peptide Vaccine Plus Dabrafenib and Trametinib
Principal investigator · Terminated · Early phase 1
Craig L Slingluff, Jr
2016–2022
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
Principal investigator · Terminated · Phase 1, Phase 2
Craig L Slingluff, Jr
2015–2019